Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2675902 | Primary Care Diabetes | 2010 | 7 Pages |
Abstract
Diabetes has become the tsunami of non-communicable chronic diseases, with its alarmingly high prevalence largely driven by the global obesity epidemic. Achieving a healthy weight and preventing weight gain are integral components of optimal diabetes management. A modest weight loss of 5–10% is associated with significant reduction in blood sugar, lipid and blood pressure levels. Insulin detemir is an effective basal insulin analogue associated with less weight gain compared with both insulin NPH and insulin glargine. Once-daily insulin detemir could be considered an effective therapy for people with type 2 diabetes on lifestyle interventions and oral anti-diabetic agent therapy who require insulin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine